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A B S T R A C T
There is increasing interest in the possibility of culturing organ-like tissues (organoids) in vitro for biomedical
applications. The ability to culture organoids would be greatly enhanced by having a functional circulation in
vitro. The endothelial cell is the most important cell type in this context. Endothelial cells can be derived from
pluripotent embryonic blastocyst cells in aggregates called embryoid bodies. Here, we examine the yield of
endothelial-like cells in embryoid bodies (EBs) developed from transgenic zebrafish fli:GFP and kdrl:GFP blas-
tocyst embryos. The isolated blastocyst cells developed into EBs within the first 24 h of culture and contained
fli:GFP+ (putative endothelial, hematopoietic and other cell types); or kdrl:GFP+ (endothelial) cells. The addi-
tion of endothelial growth supplements to the media and culture on collagen type-I substratum increased the
percentages of fli:GFP+ and kdrl:GFP+ cells in culture. We found that EBs developed in hanging-drop cultures
possessed a higher percentage of fli:GFP+ (45.0 ± 3.1%) and kdrl:GFP+ cells (8.7 ± 0.7%) than those de-
veloped on conventional substrata (34.5 ± 1.4% or 5.2 ± 0.4%, respectively). The transcriptome analysis
showed a higher expression of VEGF and TGFβ genes in EB cultures compared to the adherent cultures. When
transferred to conventional culture, the percentage of fli:GFP+ or kdrl:GFP+ cells declined significantly over
subsequent days in the EBs. The fli:GFP+ cells formed a monolayer around the embryoid bodies, while the
kdrl:GFP+ cells formed vascular network-like structures in the embryoid bodies. Differences were observed in
the spreading of fli:GFP+ cells, and network formation of kdrl:GFP+ cells on different substrates. The fli:GFP+
cells could be maintained in primary culture and sub-cultures. By contrast, kdrl:GFP+ cells were almost com-
pletely absent at 8d of primary culture. Our culture model allows real-time observation of fli:GFP+ and
kdrl:GFP+ cells in culture. The results obtained from this study will be important for the development of vascular
and endothelial cell culture using embryonic cells.
1. Introduction
Embryonic stem (ES) cells are cells derived from early embryos that
have not started to differentiate. By specific in vitro manipulation, these
ES cells can maintain their growth and pluripotency (the ability to
differentiate into multiple cell types) almost indefinitely [1]. ES cells
are important tools for regenerative medicine [2], genome manipula-
tion in animals [3], development of transgenic animals [4] and toxicity
testing [5]. Pluripotent ES cells can differentiate into specific cell types
according to the culture conditions. Examples of differentiated cell
types derived in vitro from ES cells include human cardiomyocytes [6],
human neural progenitor cells [7], mouse hematopoietic progenitor
cells [8], and alveolar epithelial cells [9]. One of the important cell
types derived from embryonic stem cell culture is endothelial pro-
genitor cells which form the epithelial lining of the cardiovascular
system [10].
Research into endothelial cells is fundamental for understanding
important processes regulated by these cells e.g. tissue homeostasis,
blood cell activation and coagulation [11]. Endothelial cell culture can
be used for important applications such as tissue regeneration. In one
study, endothelial cells derived from ES cells were transplanted into
host mice and developed into organ-specific endothelial cells which
contributed to the regeneration of liver sinusoidal vessels [12].
Similarly, vascular networks cultured in a 3D hydrogel matrix using
endothelial cells derived from human pluripotent embryonic stem cells
were able to become incorporated into the microvasculature of mouse
and sustain blood flow after implantation [13]. It is difficult to maintain
cultures of pure endothelial cells. To overcome this problem co-cul-
turing techniques have been developed, in which endothelial cells are
cultured in the presence of supporting cells including fibroblasts, mural
cells, pericytes and mesenchymal stem cells [14]. These endothelial co-
culture techniques, in combination with organoid (un-vascularized
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Culture substrates and medium composition used for the in vitro differentiation of ES cells into the endothelial lineage.[34]
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organ-like) culture [15], may be used to engineer vascularized organ
cultures [16]. In one example, human umbilical vein endothelial cells
(HUVECs) co-cultured with human mesenchymal stem cells, in a com-
bination of endothelial growth medium (EGM) and osteogenic medium,
formed an in vitro vascularized bone model [17]. It has been suggested
that such vascularized organ cultures may one day be used for tissue
transplantation [18].
Heamangioblasts, the common progenitors of endothelial and he-
matopoietic lineages, differentiate from the mesoderm during the early
development of embryos [19]. The differentiation of hemangioblasts is
initiated by various factors including vascular endothelial growth factor
(VEGF), basic fibroblast growth factor (bFGF) and bone morphogenic
protein 4 (BMP-4) [20]. Haemangioblasts can be generated in vitro by
treating ES cells with the various differentiation factors just mentioned,
as well as others used in the differentiating media (Table 1 [21]).
The in vitro differentiation of embryonic stem cells into vascular
cells has potential applications in vasculogenesis and angiogenesis re-
search, vascular regenerative therapy, vascularized organ culture and
development of endothelial cell lines [22]. In order to induce differ-
entiation, three methods have been used: (i) culture of ES cells in dif-
ferentiation media in suspension culture to form embryoid bodies (ii)
culture on a feeder cell layer of a stromal cell line (iii) culture on an
artificial matrix, e.g. collagen-IV [23,24].
Mouse ES cells cultured on the collagen-IV substrate have been
shown to differentiate along the pathway of the mesodermal lineage
with higher efficiency than the embryoid body (EB) cultures [25]. As
mesodermal cells differentiate into endothelial and hematopoietic
progenitor cells in embryos [11], collagen-IV can be used for the dif-
ferentiation of endothelial cells from ES cells [21]. As an alternative to
collagen-IV, gelatin has also been used as a substratum for mouse ES
cells to induce endothelial differentiation [21]. The differentiated en-
dothelial cells are identified using specific antibodies (reviewed in Ref.
[26]) and are enriched by cells sorting or isolation [27]. Using the same
strategy, vascular progenitor cells have been derived from mouse em-
bryonic stem cells using flk1 marker [28]. Various ES cell cultures have
been used to develop endothelial cell cultures using differentiating
media (Table 1).
ES cells from the mouse and other mammals are usually used for
endothelial differentiation assays (Table 1). However, it is desirable to
develop alternative models in order to reduce the use of mammals in
research. Zebrafish can be a model of choice for various cell culture
applications for several reasons as follows. There is no need to sacrifice
the mother to get embryos, as would be the case in mice. The zebrafish
model provides easy and large-scale availability of embryos for cell
isolation and comparatively simple conditions required for cell culture
[35]. In addition to these general advantages of zebrafish for cell cul-
ture applications, are transgenic zebrafish lines that express fluorescent
reporters in a specific cell type. This expression allows the in vivo and in
vitro observation and tracking of a particular cell-type in zebrafish
models. Two of these transgenic zebrafish reporter lines are: (i)
Kdrl:GFP, which expresses green fluorescence protein (GFP) under the
promoter of vascular endothelial growth factor receptor (VEGFR2), also
known as Flk-1 (fetal liver kinase 1) or KDR (kinase insert domain re-
ceptor) gene and which is expressed in endothelial cells [36]; and (ii)
fli:GFP, which expresses GFP under the promoter of friend leukemia
virus integration site 1, and is expressed in endothelial, lymphatic,
hematopoietic, some yolk sac and neural crest cells [37].
The zebrafish is a relatively recent research model, and in vitro
studies on zebrafish hematopoietic and endothelial cells are few, except
for a recently developed zebrafish embryonic stromal trunk cell line
that was reported to support proliferation and differentiation of zeb-
rafish hematopoietic stem cells [38]. In a recent study, we reported the
establishment of an in vitro vascular network using zebrafish embryonic
cells [39]. One of the advantages of the in vitro manipulation of zeb-
rafish cells is the availability of a large number of primary embryonic
cells, and this eliminates the necessity of developing cell lines (with
their associated drawbacks) [40]. In view of the advantages mentioned
above, zebrafish in vivo and in vitro models of vasculogenesis and an-
giogenesis would be of great importance for the initial screening of new
compounds and the testing of new protocols that could be further im-
plemented in higher organisms.
In the current study, we examine the development of fli:GFP+ and
kdrl:GFP+ cells in the EBs derived from zebrafish blastocyst cell cul-
tures. We have analyzed different strategies for the improved yield of
fli:GFP+ and kdrl:GFP+ cells in zebrafish blastocyst cell cultures.
Different media compositions, culture substrates and culture conditions
(suspension vs adherent) were used to analyze the potential of blas-
tocyst cells to generate fli:GFP+ and kdrl:GFP+ progeny in cultures.
Furthermore, the spreading of fli:GFP+ and kdrl:GFP+ cells on culture
substrata was observed and measured in growing live cultures.
2. Materials and methods
2.1. Embryo collection
All the animal experiments were performed according to the
Netherland Experiments on Animals Act, based on the guidelines on the
protection of experimental animals, laid by the Council of Europe
(1986), Directive 86/609/EC. Adult zebrafish were maintained in 5-L
tanks having continuously circulating egg water (“Instant Ocean” sea
salt 60 μg/ml demi water), on 14 h light: 10 h dark cycle. The tem-
perature of the water and air was controlled at 26 °C and 23 °C, re-
spectively. Two different transgenic zebrafish lines fli:GFP and kdrl:GFP
were used. To obtain embryos, adult male and female fish, at a ratio of
1:1, were transferred to small breeding tanks in the evening. The zeb-
rafish usually laid eggs in the morning with the first light, and the eggs
were collected at the bottom of the tank, separated from adults using a
cotton mesh to protect the eggs from being eaten.
Embryos were transferred to a temperature-controlled room (28 °C)
and were distributed in 9 cm Petri dishes at a final density of 100
embryos per dish, after removing dead and unfertilized eggs. The em-
bryos were washed thoroughly with clean egg water to remove any
debris. These embryos were allowed to develop to the high blastula stage
of Kimmel et al. [41] (approximately 3 h after fertilization) at 28 °C.
2.2. Sterilization of embryos
The embryos were transferred to a laminar flow cabinet at room
temperature for sterilization and cell isolation. For sterilization, the
embryos, with the chorion intact, were immersed in 70% ethanol for
10 s and then in two changes of 0.05% sodium hypochlorite in water
(the undiluted stock solution had an available chlorine level of 10–15%,
Sigma; Zwijndrecht; Cat. No. 425044), for 4 min each. The sterilization
was done according to the procedure described in Ref. [42]. After each
immersion in ethanol or sodium hypochlorite, the embryos were rinsed
with basic LDF medium (Table 2). Finally, the embryos were left in
0.5 ml LDF medium for dechorionation. Before dechorionating, the
embryos were observed under a dissecting microscope and any dead or
abnormal embryos (with cloudiness in the peri-vitelline fluid) were
removed.
2.3. Culturing blastocyst cells
2.3.1. Cell isolation from blastocyst embryos
The following steps were all conducted at room temperature. The
embryos were dechorionated in the LDF medium using sterile No. 5
watchmakers’ forceps and then transferred to Eppendorf tubes. The LDF
medium was gently triturated with a P-200 Gilson micropipette (Gilson,
B·V., Europe: Den Haag) to remove the yolk. The solution was then
centrifuged at 300 g for 1 min and the supernatant was discarded. The
blastocysts were washed once with CMF-PBS (calcium-magnesium-free
phosphate-buffered saline; Invitrogen; Landsmeer; Cat. No. 14190) and
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then dissociated with 1 ml of 0.25% trypsin solution (Invitrogen;
Landsmeer; Cat. No. 15090) containing 1 mM EDTA (ethylene diamine
tetraacetic acid). The trypsin solution was gently triturated with a p-
1000 Gilson pipette for 2 min. The trypsin was inactivated with 0.1 ml
FBS (fetal bovine serum; Invitrogen; Landsmeer; Cat. No. 10500) and
the cells were isolated by centrifugation at 300g for 3 min. The cells
were washed three times with LDF medium containing 15% FBS and
resuspended in 200 μl of the same medium. The cells were counted
using a hemocytometer and were plated at 17,000 cells per well in 96-
well plates to test different media compositions and culture substrates,
or 1000 cells per hanging drop (suspension) culture to develop into
embryoid bodies (see below).
2.3.2. Optimization of medium composition
To analyze the effect of medium composition on the quantification
of fli:GFP+or kdrl:GFP+cells in the cultures, different medium combi-
nations were used (Table 2). All the medium combinations contained
LDF or EGM as major components. LDF is a combination of different
nutrient media commonly used for zebrafish cell culture [42–45],
whereas EGM is usually used to culture human umbilical vein en-
dothelial cells [46,47]. EGM has also been used for the differentiation of
human pluripotent stem cells into vascular endothelial cells [13]. In our
preliminary experiments, zebrafish blastocyst cells did not grow well in
EGM. Therefore, EGM was always subsequently used in combination
with the LDF medium. In total, four different medium combinations
were prepared to culture the zebrafish blastocyst cells (Table 2).
2.3.3. Culture conditions
All cultures described here were carried out in a forced draft, hu-
midified incubator at 28 °C in 0.5% CO2. When cultures were main-
tained longer than four days, the medium was refreshed on day 4.
2.3.4. Substrates
In this experiment different substrates, namely gelatin from porcine
skin (Sigma; Zwijndrecht; Cat. No. G1890); and collagen type-I rat
protein (Invitrogen; Landsmeer; Cat. No. A1048301), were used to
culture the fli:GFP or kdrl:GFP blastocyst cells. The percentage of
fli:GFP+ or kdrl:GFP+ cells were evaluated on these substrates on
subsequent days. Gelatin was used at a concentration of 0.1 mg/cm2.
Each well of the 96-well plate was coated with 1.7 μl of 2% gelatin
solution and allowed to air dry for 1 h before the cells were plated.
Collagen type-I was used at a concentration of 3 mg/ml. To coat the
wells with collagen type-I, the solution was neutralized using 7.5%
sodium bicarbonate, and then plated at 5 μl per well in a 96-well plate.
The plate was incubated at 37 °C for 1 h to promote gel formation. The
wells were then rinsed with 1x CMF-PBS before adding the cells. The
blastocyst cells were cultured in LDF:EGS medium on these substrates.
2.3.5. Endothelial growth factors
In this experiment, the effect of recombinant zebrafish vascular
endothelial growth factor (isoform VEGF165) was evaluated on the
percentage of fli:GFP+ or kdrl:GFP+ cells in cultures. The blastocyst
cells were cultured in LDF:EGS medium supplemented with different
concentrations (0, 10, 20 and 40 ng/ml) of zebrafish VEGF165 to find
the optimum VEGF concentration for the growth of fli:GFP+ and
kdrl:GFP+ cells in culture. The cells were recovered from the 96-well
plates at days 2, 4, 6 and 8 of culture and the percentage of fli:GFP+ or
kdrl:GFP+ cells determined (see below).
2.3.6. Cell isolation from culture wells
To quantify the percentage of fli:GFP+ or kdrl:GFP+ cells, the cells
were isolated separately from each well of the 96-well plate. For cell
isolation, the medium was aspirated from each well. The cells were then
washed twice with 200 μl of 1x CMF-PBS. Then 250 μl of 0.05% trypsin
solution containing 1 mM EDTA was added to the wells. The solution
was briefly triturated in the wells and incubated for 2 min at 28 °C. The
degree of detachment was monitored under an inverted microscope.
When most cells had rounded-up, the trypsin was inactivated by adding
25 μl of FBS, and the cell suspension from each well was transferred to a
separate 1.5 ml Eppendorf tube. The suspension was centrifuged at
300 g for 3 min and the supernatant was discarded. The cell pellet was
washed twice with the basic LDF medium and re-suspended in 20 μl of
the same medium. The cells in the suspension were then counted under
a confocal microscope (see below), to quantify the percentage of
fli:GFP+ or kdrl:GFP+.
2.3.7. Quantification of fli:GFP+ or kdrl:GFP+ cells
For each of the above-mentioned culture conditions (i.e. medium
composition, substrata and VEGF concentration) and for each time-
point, the zebrafish blastocyst cells were cultured in six replicate wells
of a 96-well plate. Cultures were established in separate 96-well plates
for isolation at different time points (i.e. day 2, 4, 6 and 8). To quantify
the fli:GFP+ or kdrl:GFP+ cells in the cultures, three drops of 5 μl of
each cell suspension (isolated from the wells at different time-points)
Table 2
Medium compositions used to optimize culture conditions for the growth of fli:GFP+ and kdrl:GFP+ cells in zebrafish blastocyst cell culture.
Medium composition (supplier, catalog number) Final concentration
Basic LDF medium
Lebovitz L-15 medium (Invitrogen; Landsmeer; Cat. No. 11415); Dulbecco's modified Eagle's medium (DMEM; Invitrogen; Landsmeer; Cat. No. 11966);
Ham's F-12 medium (Invitrogen; Landsmeer; Cat. No. 21765)
55 : 32.5 : 12.5
HEPES (4-(2-hydroxyethyl)-1-piperazine-ethane sulfonic acid) 15 mM
Antibiotic/antimycotic mix (Invitrogen; Landsmeer; Cat. No. 15240) 1%
NaHCO3 0.015%
Fetal bovine serum (FBS) 15%
Zebrafish embryo extract (ZEE) 50 μg/ml
Supplemented LDF medium
Basic LDF medium 99.8%
Basic fibroblast growth factor (recombinant human protein; Invitrogen; Landsmeer; Cat. No. PHG0024) 10 ng/ml
Recombinant zebrafish VEGF165 (R&D systems; bio-techne Ltd; Abingdon; Cat. No. 1247-ZV) 10 ng/ml
LDF:EGM medium
Supplemented LDF medium 50%
Endothelial growth medium-2 (Promocell; bio-connect B·V.; Huissen; Cat. No. C-22011) 50%




Basic LDF medium 95.8%
Endothelial growth supplement mix (Promocell; bio-connect B·V.; Huissen; Cat. No. C-39216) 4.1%
Recombinant zebrafish VEGF165 10 ng/ml
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were transferred to the confocal microscope on a cover glass slide. The
cells were allowed to settle (for 30 s) and then the cell population of
each 5 μl drop was imaged in duplicate, one with 488 nm wavelength
excitation light to visualize the fli:GFP+ or kdrl:GFP+ cells, and one
with phase-contrast showing all the cells. Multiple images were taken
from each droplet if necessary to capture all the cells. For both fli:GFP
and kdrl:GFP cultures, the number of GFP+ and GFP− cells in the mi-
croscopic fields (images) per sample were then counted in ImageJ
software version 1.46r [48]. From these counts, the percentage of
fli:GFP+ or kdrl:GFP+ cells was calculated for each culture well.
2.4. Culturing embryoid bodies
2.4.1. Hanging-drop (HD) cultures
The blastocyst cells isolated from fli:GFP or kdrl:GFP embryos ac-
cording to the above-mentioned protocols, were re-suspended (at a final
concentration of 50 cells/μL) in EB induction medium (LDF medium
supplemented with 4.1% EGS, 20% FBS, 50 μg/ml ZEE, 40 ng/ml
zebrafish VEGF165 and 10 ng/ml bFGF). The cell suspension was dis-
tributed in 20 μl droplets (containing 1000 blastocyst cells each) onto
the inside of the lids of 60 mm Petri dishes with no pre-treatment of the
substratum. The lids with the droplets were inverted and replaced on
the Petri dishes to initiate the hanging drop (HD) cultures. To diminish
evaporation from the droplets, enough CMF-PBS was added to cover the
area of each Petri dish (approximately 5 ml). The cultures were main-
tained in the incubator for four days to allow the formation of embryoid
bodies (EBs). These EBs were then used to evaluate the fli:GFP+ or
kdrl:GFP+ cells population overtime. On day 4 the EBs were transferred
to the adherent culture conditions (see below) for further development.
2.4.2. Isolation of EBs
To isolate the EBs, the Petri dish lid was carefully inverted and held
at a 45° angle. The droplets containing the EBs were shaken down to
one side of the lid by gently tapping the lid. The EBs were transferred to
a 1.5 ml Eppendorf tube using a p-1000 micropipette and were allowed
to settle to the bottom of the tube by gravity. The medium was removed
and the EBs were washed with the basic LDF medium. Finally, the EBs
were re-suspended at 20 EB per 250 μl of EB maturation medium (LDF
medium supplemented with 4.1% EGS, 15% FBS, 50 μg/ml ZEE, 40 ng/
ml zebrafish VEGF165 and 10 ng/ml bFGF), to be re-plated in 96-well
plates.
2.4.3. Quantification of fli:GFP+ or kdrl:GFP+ cells in EBs
The fli:GFP or kdrl:GFP EBs isolated from the HD cultures were sub-
cultured in 96-well plates, without extra substrate coating. The EBs
were distributed in 96-well plate at 20 EBs in 250 μl medium (as re-
suspended after isolation; see above) per well. For each transgenic line,
a total of four 96-well plates were seeded with the EBs to analyze the
cell counts at four consecutive time-points (days 2, 4, 6 and 8; one plate
for one time-point). For each time-point six replicate wells of the 96-
well plate were seeded with the EBs. The percentage of fli:GFP+ or
kdrl:GFP+ cells were also calculated in the EBs on day 0 (the time of
harvesting of the EBs from the HD culture, that is, day 4 of HD culture).
For cell counts on day 0, six replicates of 20 EBs per Eppendorf tube
were dissociated into single cells using 250 μl of 0.05% trypsin solution.
For each time point, cells were isolated from the culture wells as de-
scribed above (Cell isolation from culture wells) and the contents of
each well were transferred to a separate Eppendorf tube. The percen-
tage of fli:GFP+ or kdrl:GFP+ cells was determined in these cultures
according to the above procedure (Quantification of fli:GFP+ or
kdrl:GFP+ cells).
2.4.4. Quantification of fli:GFP+ cells in EBs secondary cultures
For this experiment, the fli:GFP EBs were cultured in EB maturation
medium for 8 days in a 24-well plate. A total of three wells (replicates)
were cultured with 100 EBs per well. On day 8, the cells were then
isolated from each well using 1 ml of 0.05% trypsin. The cells from each
well were transferred to one well of a new 24-well plate (passage 1).
The procedure was repeated on day four and the cells were sub-cultured
in a fresh 24-well plate (passage 2). During the transfer, a small volume
of cell suspension from each replicate was used to determine the per-
centage of fli:GFP+ cells (as described above). The passage 2 cells were
cultured for another four days in the same medium and used again to
calculate the percentage of fli:GFP+ cells in each well.
2.4.5. Culture of fli:GFP EBs on different substrates
In order to observe the development of fli:GFP+ cells in culture, the
EBs were cultured on three different substrates: (i) gelatin (Sigma;
Zwijndrecht; Cat. No. G1890); (ii) collagen type-I (Invitrogen;
Landsmeer; Cat. No. A1048301); (iii) fibrin, made with bovine fi-
brinogen (Sigma; Zwijndrecht; Cat. No. F8630). In order to image the
cultures with a confocal microscope, a CS16-chambered cover glass
plate (Grace Bio-Labs; bio-connect B·V.; Huissen; Cat. No. 112358) was
used for these experiments. Gelatin was used at a concentration of
0.1 mg/cm2 for coating the culture well. The well with gelatin-coating
was allowed to air-dry before adding the EBs. The collagen type-I so-
lution was prepared at 3 mg/ml and neutralized with 0.0125 ml/ml of
7.5% sodium bicarbonate. The collagen type-I gel solution was added at
5 μl per well to coat the well and allowed to polymerize at 37 °C for
30 min.
The fibrin gel was prepared by mixing fibrinogen solution (at a final
concentration of 2.5 mg/ml) with 3 Units/ml of thrombin solution
(Sigma; Zwijndrecht; Cat. No. T4648). The well was coated with 5 μl of
the mixture. The plate was incubated at 37 °C for 30 min. All the wells
coated with different substrate molecules were rinsed with the basic
LDF medium before adding the EBs. The EBs re-suspended in the EB
maturation medium was distributed at 20 EBs per well for each sub-
strate condition.
2.4.6. Culture of kdrl:GFP EBs on different substrates
The kdrl:GFP EBs were transferred to different gel substrates namely
collagen type-I, Geltrex™ and combined collage type-I + Geltrex™. A
single well of the CS16-chambered coverglass plate was coated with
each of the gel substrates. The collagen type-I gel mixture was prepared
as above (3 mg/ml) and 5 μl of the mixture was used to coat the well.
Similarly, another well was coated with 5 μl of Geltrex™ (Invitrogen;
Landsmeer; Cat. No. A1413201). Geltrex™ has, according to the man-
ufacturer's documentation, as its major components, laminin, collagen
type-IV, entactin and heparin sulfate proteoglycans and has a total
protein concentration of 12–18 mg/ml. A combination of collagen type-
I and Geltrex™ with a final concentration of 1.5 mg/ml and 6–9 mg/ml,
respectively, were also used as a substratum (5 μl per well). After
coating the wells with the gel mixtures, the plate was incubated at 37 °C
for 30 min. The wells were then rinsed with the LDF medium. Finally,
20 kdrl:GFP EBs per 250 μl of EB maturation medium was added to each
well.
2.4.7. Culture of kdrl:GFP EBs in a 3D gel matrix
In this experiment, the kdrl:GFP EBs were embedded and cultured in
a 3D gel matrix composed of collagen type-I, Geltrex™ and fibrin (2.5,
6–9 and 2 mg/ml, respectively). Before embedding EBs in the gel, a well
of the CS16-chambered cover glass plate was coated with 5 μl of the gel
mixture. The plate was incubated at 37 °C for 30 min. To make a 3D
culture, the calculated volumes of the gel constituents were mixed with
the EBs isolated from the hanging drop cultures. Ten microliters of the
gel mixture containing 20 EBs were then plated in the pre-coated well.
The gel with the EBs was allowed to polymerize for 30 min at 28 °C.
Finally, 250 μl of EB maturation medium was added to the well. The
cultures were maintained at 28 °C and were imaged on consecutive days
under the confocal microscope.
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2.5. Image analysis
Selected embryoid bodies showing colonies of fli:GFP+ or kdrl:GFP+
cells were imaged on consecutive days using a confocal microscope
(Axio observer inverted microscope A1). The fli:GFP+ or kdrl:GFP+
cells were visualized with 488 nm wavelength excitation light for
imaging. Image-J software, version 1.46r [48] was used to reconstruct
the images for further analysis. The EB cultures were observed from day
one until day 12 to analyze changes in the following measurements of
fli:GFP+ or kdrl:GFP+ cells in culture. For all the measurements, a pre-
calibrated scale was used.
2.6. Measurement of the area covered by fli:GFP+ cells per EB
The area covered by fli:GFP+ cells around the EB, at each time-
point, on different substrates, was measured. From these measure-
ments, the percentage change in area covered by fli:GFP+ cells at each
time-point, compared to day one, was calculated for each individual EB.
2.7. Measurement of kdrl:GFP+ cell networks in EBs
The kdrl:GFP+ cell network formed in the EBs was measured from
the confocal images at consecutive days. The parameters for these
measurements were: (i) lengths of individual kdrl:GFP+ branches per
EB; (ii) average width of the branches; (iii) number of branches per EB
and (iv) total length of the kdrl:GFP+ cell network per EB.
Calculation of connectedness of the kdrl:GFP+ cell network.
The connectedness of the kdrl:GFP+ cell networks formed per EB
was calculated using the following formula:
Network connectedness = Number of endpoints
number of junctions
Theoretically, for a well-connected network, the value obtained
should be close to zero [49].
2.8. Statistical analysis
The percentages of fli:GFP+ or kdrl:GFP+ cells per well, recorded in
6 replicates (wells) for each condition at each time-point, were ana-
lyzed for means and standard errors using SPSS software version 21.0.
Area covered by fli:GFP+ cells, and measurements of kdrl:GFP+ cell
networks, were analyzed for mean and standard error per EB using SPSS
software. One-way ANOVA was performed to calculate the probability
values in order to analyze variation between different conditions. Pair-
wise comparisons of conditions having more than two groups were
evaluated by the Post-Hoc Tukey's test. The comparisons showing p
values of 0.05 or less were considered significantly different.
2.9. Transcriptome analysis of cell cultures
2.9.1. Preparation of cell cultures for RNA isolation
A total number of 14 RNA samples were extracted from the blas-
tocyst cells and EB cultures at successive time points (day 0, day 2, day
4 and day 6). Two replicates were established for both culture types for
each time point. The gene expression in the blastocyst embryos (3.5 h
post-fertilization) was considered as day 0 time-points for both culture
types. The blastocyst embryos were used to isolate embryonic cells,
which were then used to establish EB and blastocyst cell cultures (ac-
cording to the above-mentioned procedures). The blastocyst cell cul-
tures from day 0 and the EB cultures from day 4 (after isolation from
HD culture) were maintained in 48-well plates. All the cultures were
maintained in LDF:EGS medium supplemented with 40 ng/ml VEGF165.
2.9.2. RNA isolation from culture
For RNA isolation at day 0, a total number of 20 blastocyst embryos
were dechorionated, washed with cell culture medium and then mixed
with 500 μl of Trizole, in a 1.5 ml Eppendorf tube. For RNA isolation at
subsequent days of cultures, the medium was removed from 20 EBs or
one well of 48-well plate, and 500 μl Trizole was added. The cells/EBs
suspended in Trizole were mixed well using a 1 ml syringe with a 21-
gauge needle, in order to mechanically disrupt the cell membrane. The
solutions were left at room temperature for 5 min. Then, 100 μl of
chloroform was added to each tube and shacked vigorously. The tubes
were left at room temperature for 2–3 min. The tubes were then cen-
trifuged at 12,000 g for 15 min at 4 °C. The aqueous phase containing
RNA was transferred to a new tube. The RNA was precipitated using
250 μl of isopropanol and then centrifuged at 12,000 g for 10 min at
4 °C. The supernatant was removed, and the RNA pellet was washed
once with 75% ethanol. The ethanol was discarded after centrifugation
and the pellet was allowed to air dry for 20–30 min. The RNA pellet was
resuspended in 40 μl of RNAse free water, incubated in a heat block at
56 °C for 10–15 min, and stored at −70 °C until transcriptome analysis.
2.9.3. RNA-seq and bioinformatics analysis
All 14 RNA samples were sent to BaseClear (Leiden, Netherlands)
for RNA sequencing. The RNA samples were thoroughly quality
checked before transcriptome analysis. For each of the 14 samples,
single-end sequence reads were generated using the Illumina HiSeq
2500 system. FASTQ sequence files were generated using bcl2fastq2
version 2.18 (Illumina's software). To get clean data, initial data quality
was assessed by passing the Illumina Chastity filtering. Then, those
reads containing PhiX control signal were removed by an in-house fil-
tering script (offered by BaseClear). Finally, reads containing (partial)
adapters were clipped (up to minimum read length of 50bp). After
clipping, we got clean data. Then with Tophat 2 [50], we aligned RNA-
Seq reads to the zebrafish genome (downloaded from Ensembl [51]).
After alignment, we assembled the aligned RNA reads and calculated
the FPKM (Fragments Per Kilobase of transcript per Million mapped
reads) value for the transcripts with Cufflinks package [52]. Finally, we
did reads normalization and got the relative genes expression with R
package cummeRbund version 2.28.0.
3. Results
3.1. Medium composition effects the development of fli:GFP+ and
kdrl:GFP+ cells in blastocyst cell culture
3.1.1. Effect of medium composition on quantification of fli:GFP+ cells
The blastocyst cells isolated from fli:GFP embryos showed expres-
sion of the fli:GFP marker in cells in culture medium with or without
endothelial growth supplements. Blastocyst cells formed embryoid
bodies within the first 24 h, and these cultures contained 2.2 ± 0.4%
fli:GFP+ cells. Initially, the fli:GFP expression was observed only on the
periphery of the embryoid bodies (Fig. 1A). In the subsequent days,
spreading of the fli:GFP+ cells were observed around the EBs (Fig. 1B).
After day 4 in basic LDF medium, the population fli:GFP+ cells declined
significantly (Figs. 1C and 2A). However, in the LDF medium with
added endothelial growth medium or supplements, the population of
fli:GFP+ cells could be maintained up to eight days (Fig. 1D, E, F and
Fig. 2A).
The fli:GFP+ cells were flattened and did not form the networks seen
with kdrl:GFP+ (see below). Different medium compositions used to
culture zebrafish blastocyst cells showed significant differences in the
percentage of fli:GFP+ cells in cultures (Fig. 2A). The percentage of
fli:GFP+ cells were significantly higher in supplemented LDF, LDF:EGM
and LDF:EGS media compared to the basic LDF medium (p < 0.001).
When different supplemented LDF media were compared, the percen-
tage of fli:GFP+ cells were significantly higher in cultures maintained
on LDF:EGM and LDF:EGS media compared to the cultures maintained
on supplemented LDF medium at each time-point (Fig. 2A). No sig-
nificant differences in the percentage of fli:GFP+ cells were observed
between LDF:EGM and LDF:EGS medium except on day 6, when a
higher percentage of fli:GFP+ cells were found in LDF:EGM medium
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(p < 0.01). Although the percentage of fli:GFP+ cells was higher in
cultures maintained on LDF:EGM medium, a lower number of total cells
(9584 ± 733) was harvested per well for this medium on day 8 of
culture, compared to the LDF:EGS (12,987 ± 1092) and supplemented
LDF medium (20,457 ± 880).
3.1.2. Percentage of kdrl:GFP+ cells in cultures maintained with different
medium compositions
The percentage of kdrl:GFP+ cells was similar in different medium
compositions until day 4 of culture (Fig. 2B). After day 4 the blastocyst
cells cultured in the basic and supplemented LDF media contained a
significantly lower percentage of kdrl:GFP+ cells compared to the
LDF:EGS and LDF:EGM media. The percentage of kdrl:GFP+ cells in
cultures maintained with LDF:EGS medium was slightly higher com-
pared to the LDF:EGM medium; however the differences were not sig-
nificant. The quantification of kdrl:GFP+ cells at subsequent time points
showed a slight increase in percent kdrl:GFP+ cells from day 2 to day 4
and then a decrease after day 4. In the basic and supplemented LDF
media the percentage of kdrl:GFP+ cells dropped significantly from day
4 to day 6 (p < 0.01) and then continued to decline until day 8. A
decrease in the percentage of kdrl:GFP+ cells was also observed in
LDF:EGM and LDF:EGS media between day 4 and day 8 (p < 0.05).
The highest percentage of kdrl:GFP+ cells (4.2 ± 0.3%) was found on
day 4 in cultures maintained in LDF:EGS medium.
3.2. Effect of culture substrate on the quantification of fli:GFP+ and
kdrl:GFP+ cells in blastocyst cell culture
3.2.1. Effect of substratum on the percentage of fli:GFP+ cells
A higher percentage of fli:GFP+ cells was found in cultures on col-
lagen type-I compared to gelatin substratum (Fig. 3A). The cells were
also cultured without any substrate coating on the polystyrene surface
of the tissue culture plate for comparison. All the cultures were main-
tained in LDF:EGS medium. Compared to the uncoated wells, the per-
centage of fli:GFP+ cells was slightly lower in gelatin-coated wells, and
higher in collagen type-I coated wells. The images showed more flat-
tened morphology of fli:GFP+ cells on collagen type-I and polystyrene
substrates, compared to gelatin substratum where the fli:GFP+ cells
remained on the periphery of the embryoid bodies (Fig. 1). The per-
centage of fli:GFP+ cells in samples isolated on day 8 of the cultures was
Fig. 1. Formation of fli:GFP+ cell colonies in zebrafish blastocyst cell culture under different conditions. (A) Within the initial 24 h of culture, the cells
combine to form aggregates called embryoid bodies. Arrows showing the appearance of fli:GFP+ cells on the periphery of embryoid bodies. (B) More fli:GFP+ cells
appear and proliferate around the embryoid bodies by day 4 of culture. (C) By day 6 in basic LDF medium (with no additional supplementation) the fli:GFP+ cells
diminish in culture, arrows showing elongated, non-GFP, fibroblast-like cells continue to proliferate around the EBs. More fli:GFP+ cells were observed on day 6 in
cultures maintained with (D) supplemented LDF,(E) LDF:EGM and (F) LDF:EGS media compared to the basic LDF medium. (G) The blastocyst cells cultured on
gelatin-coated wells, showing the fli:GFP+ cells on the periphery of embryoid bodies. (H) On collagen type-I substratum comparatively smaller embryoid bodies are
formed with the outgrowths of fli:GFP+ cells. (I) Counting of fli:GFP+ cells in the cells isolated from the blastocyst cell cultures. All the images are overlaid confocal
image showing fli:GFP+ cells, and a phase-contrast image. Scale bar = 100 μm.
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significantly higher on collagen type-I (30.6 ± 2.0%) compared to
gelatin (20.9 ± 1.6%; p < 0.01) substratum (Fig. 3A).
3.2.2. Effect of substratum on the percentage of kdrl:GFP+ cells
The blastocyst cells cultured on different substrates showed a higher
percentage of kdrl:GFP+ cells on collagen type-I substratum compared
to gelatin substratum at different time-points (Fig. 3B). The percentages
of kdrl:GFP+ cells obtained from these substrates were compared with
cultures on tissue culture-treated polystyrene surface without coating.
However, the differences between collagen type-I and the polystyrene
substrate were not significant. The percentage of kdrl:GFP+ cells
dropped significantly from day 4 to day 8 on all the three substrates.
3.3. VEGF effects the quantification of fli:GFP+ and kdrl:GFP+ cells in
blastocyst cell culture
3.3.1. Effect of VEGF on the percentage of fli:GFP+ cells
The recombinant zebrafish vascular endothelial growth factor
(VEGF165) protein showed a significant effect on the percentage of
fli:GFP+ cells in cultures (Fig. 4A). A higher percentage of fli:GFP+ cells
was observed in cultures with 10–40 ng/ml VEGF165 in the medium
compared to cultures maintained on medium without VEGF, at each of
the time point (p < 0.001). On day 2 of the cultures, no significant
differences were observed in the percentage of fli:GFP+ cells in cultures
grown in media with different VEGF165 concentrations (10, 20 and
40 ng/ml). However, after day 4 the cells cultured on medium with
40 ng/ml VEGF165 contained a significantly higher percentage of
fli:GFP+ cells compared to 10 ng/ml VEGF165 (p < 0.01 for day 4 and
day 6; p < 0.001 for day 8). No significant differences in the per-
centage fli:GFP+ cells was observed in blastocyst cells cultured on 10
and 20 ng/ml VEGF165, at different time points except on day 8
(p < 0.05). Similarly, no significant differences were observed be-
tween 20 and 40 ng/ml VEGF165 cultures at different time points
(Fig. 4A).
3.3.2. Percentage of kdrl:GFP+ cells in media with different VEGF
concentrations
No significant differences in the percentage of kdrl:GFP+ cells were
observed with different VEGF165 concentrations on day 2 of culture.
From day 2–4 the percentage of kdrl:GFP+ cells increased in all cul-
tures; however, the increase was greater in cultures with 40 ng/ml
VEGF165 compared to cultures without VEGF165 in the medium
(Fig. 4B). In the subsequent days the percentage of kdrl:GFP+ cells
decreased significantly in cultures without VEGF165 (P < 0.01).
However, in cultures with 20 and 40 ng/ml VEGF165 a higher percen-
tage of kdrl:GFP+ cells was maintained until day 8. This resulted in a
higher percentage of kdrl:GFP+ cells in cultures with VEGF165 com-
pared to cultures without VEGF165 on days 6 and 8.
Fig. 2. Percent quantification of (A) fli:GFP+ cells and (B) kdrl:GFP+ cells
in blastocyst cell cultures over time. (A) The graph shows a significant in-
crease in the percentage of fli:GFP+ cells with the addition of endothelial
growth supplements to the medium, compared to the basic LDF medium. (B)
The blastocyst cells cultured in LDF:EGS medium maintained a higher per-
centage of kdrl:GFP+ cells until day 8 of culture. In other media compositions
the percentage of kdrl:GFP+ cells dropped significantly after day 4 of culture.
The number of observations was six per medium per time-point. Error bars
represent standard error. (***, p < 0.001, **, p < 0.01, *, p < 0.05 com-
pared to basic LDF medium; ###, p < 0.001, ##, p < 0.01, #, p < 0.05
compared to supplemented LDF medium).
Fig. 3. Percentage of (A) fli:GFP+ cells and (B) kdrl:GFP+ cells in cultures
maintained on different substrates. (A) The graph shows a higher percentage
of fli:GFP+ cells on collagen type-I compared to gelatin substratum on days 4
and 8. (B) Similarly, a higher percentage of kdrl:GFP+ was observed on collagen
type-I compared to gelatin substratum on days 2, 4 and 8. The number of ob-
servations was six per substrate per time-point. Error bars represent standard
error. (*, p < 0.05 compared to polystyrene; ##, p < 0.01, #, p < 0.05
compared to gelatin).
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3.4. Quantification of fli:GFP+ and kdrl:GFP+ cells in EBs developed in
hanging drop cultures
3.4.1. Percentage of fli:GFP+ cells in EBs
The fli:GFP EBs contained a high percentage of fli:GFP+ cells on day
0 (45.0 ± 3.1%), i.e. directly after isolation from the hanging drop
cultures. When transferred to a conventional 96-well plate, the per-
centage of fli:GFP+ cells dropped gradually with time (Fig. 5A). No
significant decrease in the percentage of fli:GFP+ cells was observed, on
day 2 and day 4 after transferring to the 96-well plate. However,
compared to day 2, a significant decrease in the percentage of fli:GFP+
cells was observed on day 6 (p < 0.01) and day 8 (p < 0.001). The
percentage of fli:GFP+ cells in cultures on days 6 and 8 was less than
half of the percentage found in EBs on day 0 (p < 0.001).
3.4.2. Percentage of kdrl:GFP+ cells in EBs
Similar to the results obtained for fli:GFP+ cells, a higher percentage
of kdrl:GFP+ cells was found in EBs on day 0 (8.7 ± 0.7%; Fig. 5B), i.
e. directly after isolating from the hanging drop cultures, compared to
the following days. These EBs, when transferred to a 96-well plate on
conventional substratum, showed a significant decrease in the percen-
tage of kdrl:GFP+ cells on day 2 (3.4 ± 0.5%; p < 0.001). This was
followed by a gradual decrease at each time-point until day 8 (Fig. 5B).
The percentage of kdrl:GFP+ cells in EB cultures on day 8 was
significantly less than the percentage value on day 2 (p < 0.05).
3.4.3. Percentage of fli:GFP+ cells in EB secondary culture
In this experiment, the fli:GFP EB cultures maintained for eight days
in a 24-well plate were isolated by trypsinization and sub-cultured on a
new plate. The sub-cultured (passage 1) cells were maintained in the
medium for four days (Fig. 6A) and then isolated and counted for the
percentage of fli:GFP+ cells. The passage 1 EB cultures contained
15.1 ± 1.9% fli:GFP+ cells. These cultures were then re-plated for
another passage (passage 2) and maintained for another four days. The
percentage of fli:GFP+ cells in passage 2 cultures was 13.1 ± 0.8%.
Although the percentage of fli:GFP+ cells was more or less stable in sub-
cultures, the intensity of the GFP signal from the cells greatly reduced in
the second passage (Fig. 6B).
3.5. Development of fli:GFP+ and kdrl:GFP+ cells in EB culture
3.5.1. Increase in the area covered by fli:GFP+ cells in EB culture on 2D
substrates
The fli:GFP+ cells propagated in the form of a monolayer around the
EBs (Fig. 6D–F). The area covered by the fli:GFP+ cells emerging from
the EBs on different substrates (i.e. collagen type-I, gelatin and fibrin)
was measured on every second day (day 2, 4, 6, 8, 10 and 12) from the
confocal images. The percentage increase in surface area covered by
fli:GFP+ cells, compared to the same value on day 1, was calculated at
each time-point for individual EBs. On collagen type-I substratum, a
Fig. 4. Percentage of (A) fli:GFP+ cells and (B) kdrl:GFP+ cells in cultures
maintained on increasing concentrations of zebrafish VEGF165. (A) A sig-
nificant increase in the percentage of fli:GFP+ cells is shown in cultures
maintained on medium with (10, 20 or 40 ng/ml) VEGF165 compared to cul-
tures on medium without (0 ng/ml) VEGF165 at different time-points. (B) The
blastocyst cells cultured in the presence of VEGF165 maintained a significantly
higher percentage of kdrl:GFP+ cells compared to cultures without VEGF165
overtime. The number of observations was six per VEGF concentration per time-
point. Error bars represent standard error. (***, p < 0.001, **, p < 0.01, *,
p < 0.05 compared to cultures without VEGF165 in the medium; ###,
p < 0.001, ##, p < 0.01, #, p < 0.05 compared to medium with 10 ng/ml
VEGF165).
Fig. 5. Changes in the percentage of (A) fli:GFP+ cells and (B) kdrl:GFP+
cells over time in EB cultures. Day zero for EBs is the day four of hanging
drop cultures. The EB cells were isolated from cultures at each time-point (days
2, 4, 6 and 8) to quantify the percentage of fli:GFP+ or kdrl:GFP+ cells. (A) A
decrease in the percentage of fli:GFP+ cells can be observed at each time-point.
(B) An abrupt decrease from day 0 to day 2 and then a gradual decrease after
day 2 can be seen in the percentage of kdrl:GFP+ cells. The number of ob-
servations was six per time-point. Error bars represent standard error. (**,
p < 0.001 compared to day 0; ###, p < 0.001, ##, p < 0.01, #, p < 0.05
compared to day 2; +, p < 0.05 compared to day 4).
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significant increase in area covered by fli:GFP+ cells was observed be-
tween day 6 and day 8 (p < 0.05). On gelatin substratum, the area
covered by fli:GFP+ cells slowly increased from day 2 to day 6
(p < 0.01). On fibrin substratum, the area covered by fli:GFP+ cells
increased significantly from day 2 to day 4 (p < 0.001). After day 8, no
further increase in the area covered by fli:GFP+ cells was observed on
any of the three substrates.
Differences in percent increase in area covered by fli:GFP+ cells
were observed between different substrates from day 2 to day 6 (Fig. 7).
During these days of cultures, the fli:GFP+ cells covered significantly
more area per EB on fibrin substratum compared to gelatin and collagen
type-I. Due to the gradual increase in the percent area covered
by fli:GFP+ on collagen type-I and gelatin substrate, no significant
differences were observed between the three substrates after day 8 of
culture.
3.5.2. Network-formation by kdrl:GFP+ cells in 2D and 3D cultures
Unlike the fli:GFP+ cells, which showed a fibroblastic morphology
in culture, the kdrl:GFP EBs showed cell-cell extensions of kdrl:GFP+
cells, forming cord or network-like structures on 2D substrates (i.e.
collagen type-I, Geltrex™, and combined collagen type-I + Geltrex™),
and in 3D gel matrix (composed of collagen type-I, Geltrex™ and fibrin)
(Fig. 8). Analysis of total length of the kdrl:GFP+ cell network per EB
and length of individual kdrl:GFP+ branches per EB showed significant
differences between 2D and 3D cultures (Fig. 9). In general, network
formation by kdrl:GFP+ cells in EBs was enhanced in 3D culture, in-
cluding fibrin as a component, compared to the 2D cultures on other
substrates. No significant differences were observed in the total length
of the kdrl:GFP+ cell network per EB on different 2D substrates except
between collage type-I + Geltrex™ and collagen type-I substrate on day
6 (p < 0.05).
The total network length per EB was significantly higher in 3D
culture containing fibrin as a component, compared to all the three 2D
substrates (with no fibrin added) on day 4 and day 6 (Fig. 9A). The
network length reduced significantly on 2D collagen type-I substratum
from day 2 to day 6 (p < 0.05). On 2D Geltrex™ and 2D collage type-
I + Geltrex™ substrates, the network length remained similar at sub-
sequent time-points. In 3D culture, a significant reduction in the total
network length per EB was observed from day 4 to day 12 (p < 0.001).
On day 12, the total network length in all the 2D and 3D cultures was
similar. The individual kdrl:GFP+ branch length per EB was also higher
in 3D culture compared to 2D substrates at different time-points
(Fig. 9B). Other parameters i.e. the number of kdrl:GFP+ branches per
EB and average branch width remained similar between the 2D and 3D
cultures (data not shown).
3.5.3. Connectedness of the kdrl:GFP+ network
The connectedness values of kdrl:GFP+ cell networks on different
substrates are given in Fig. 10. On 2D collagen type-I + Geltrex™ and in
3D collagen type-I + Geltrex™ + fibrin gel matrix, the network formed
Fig. 6. Confocal images showing fli:GFP+ cells in EB cultures. The EB cells not expressing GFP are shown in phase contrast overlaid. (A) Secondary EB culture
(passage 1) on day 4 showing fli:GFP expression in multiple cells. (B) Secondary EB culture (passage 2) the intensity of the signal is visibly lower than the passage
1 cells. (C) Drop of cell suspension used for the counting of fli:GFP+ cells in the cell-isolates from the EB cultures. (D) Spreading of fli:GFP+ cells in EB culture on
collagen type-I substratum on day 6. (E) EB cultured on gelatin substratum on day 6. (F) EB cultured on fibrin substratum on day 6. Scale bar = 100 μm.
Fig. 7. Percentage increase compared to day 1, in the surface area covered
by fli:GFP+ cells per EB on different culture substrates. The number of
observations was 13 for collagen type-I, 12 for gelatin and nine for fibrin per
time-point. Error bars represent standard error. (***, p < 0.001, **, p < 0.01,
*, p < 0.05 compared to collagen type-I; ##, p < 0.001, #, p < 0.01
compared to gelatin).
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by the kdrl:GFP+ cells was more connected compared to collagen type-I
substratum. In 3D gel matrix, the connectedness values remained con-
stant over the 12 days of culture. While on 2D collagen type-I sub-
stratum the kdrl:GFP+ cell network was well connected on day 1 of
culture with lower endpoints divided by junctions value. However, the
connectedness of the network on this substratum was lost with the
duration of culture.
3.6. Transcriptome profiling of blastocyst cell and EB culture
Transcriptome analysis of the blastocyst cell and EB cultures re-
vealed the differential expression of certain genes in both cultures
(Fig. 11). The blastocyst cell culture represented an adherent culture
while the EBs were cultured in suspension (HD) until day 4. The FPKM
values of the transcripts showed that certain endothelial differentiation
markers were expressed at a higher level, on day 6 of culture, in EB
cultures compared to the blastocyst cell cultures. These markers in-
cluded both the VEGF variants (vegfab and vegfaa), and several genes
of the TGFβ family (tgfbrap1, tgfbr2a, tgfbr1b, tgfbr1a, tgfb2, tgfb1b
and tgfb1a). On the preceding days of cultures, the FPKM values of
these genes were similar in both culture types. One endothelial differ-
entiation marker ‘tgfbi’ showed higher FPKM values in blastocyst cell
cultures compared to the EB cultures on all time-points. The marker
‘tgfbrap1’ showed a higher expression in early blastocyst embryos
compared to the cultured cells.
Among the endothelial maturation markers, the FPKM values of the
Notch receptors (notch1a and notch1b) were higher in EB cultures
compared to the blastocyst cell cultures on all time-points (Fig. 11).
However, the Notch ligands (jag1a, jag1b and jag2a) showed little
variation in their FPKM values among the two culture types. The
pluripotency marker pou5f3 expressed at a high level in early blastocyst
embryos. No expression of pou5f3 was detected in blastocyst cell cul-
tures at all time-points. In EB cultures, however, a small expression of
pou5f3 was observed in one replicate on day 2 of culture. The pro-
liferation marker eef1a1l1 showed higher FPKM values in the adherent
blastocyst cell culture compared to the EB cultures, in which the FPKM
values gradually diminished with culture duration.
4. Discussion
We have investigated different culture conditions for zebrafish
blastocyst cells, with the objective of generating differentiated en-
dothelial-like fli:GFP+ or kdrl:GFP+ cells in relatively high numbers.
We have shown that the endothelial differentiation process in zebrafish
Fig. 8. Development of EBs from zebrafish kdrl:GFP blastocyst cells. (A) The blastocyst cells cultured on plastic on day 4 contain kdrl:GFP+ cells. (B) By day 6 the
number of kdrl:GFP+ cells diminishes on plastic. (C) On collagen type-I substratum the kdrl:GFP+ cells can still be observed on day 6 of culture (D) kdrl:GFP embryoid
body on day 4 of hanging drop culture. (E) When transferred to adherent culture the kdrl:GFP+ cells make cell-to-cell extensions. The image on day 4 of the adherent
culture maintained on 2D collagen type-I substratum. (F) On 2D Geltrex™ susbtratum the kdrl:GFP+ cell network form inside the EB. (G) EB on 2D collagen type
I + Geltrex™ substratum on day 6 of culture. (H) More extensive network formation in 3D collagen type-I + Geltrex™ + fibrin gel matrix. The image was taken from
the junction of three adjacent EBs. (I) Quantification of kdrl:GFP+ cells in a drop of cell suspension isolated from culture. Scale bar = 100 μm.
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blastocyst cell cultures is critically influenced by the culture conditions.
We also found that the ability to form network-like cell connections is
largely confined to the kdrl:GFP+ cells and 3D culture. Here we discuss
the important factors which influence the growth and differentiation of
fli:GFP+ and kdrl:GFP+ cells in culture.
4.1. fli:GFP+ versus kdrl:GFP+ cells
The blastocyst cell cultures initiated from fli:GFP embryos in our
experiments expressed GFP in a higher percentage of cells compare to
the kdrl:GFP+ cellscells. This might be explained by the lineage-speci-
ficity of GFP expression in kdrl:GFP transgenic lines (endothelial cells
only) [53], compared to the fli:GFP line (endothelial, lymphatic, he-
matopoietic, some yolk sac and neural crest cells) [37]. The differences
in morphology and growth pattern of fli:GFP+ and kdrl:GFP+ cells, in
our study, also showed the specificity of kdrl:GFP marker for en-
dothelial cells. In contrast to the fibroblast-like morphology of fli:GFP+
cells, the endothelial-like morphology of kdrl:GFP+ cells is manifested
by the network formation of these cells. In some cases the network or
cord-like structures could also be observed in fli:GFP+ blastocyst and
EB cultures; however, it was difficult to differentiate it from the other
fibroblastic GFP+ cells in these cultures.
The kdrl:GFP+ cells disappeared after a maximum of eight days
under all of the culture conditions tested in blastocyst cell culture. One
of the reasons for this could be apoptosis, as reported in a recent study
using kdrl:GFP blastocyst cells for screening angiogenic and anti-an-
giogenic compounds [54]. However, in contrast to Ref. [54], in our EB
cultures the kdrl:GFP+ cell networks could be observed up to 12 days in
culture. Similarly, the fli:GFP signals could be observed for up to 12
days of primary cultures and in secondary cultures for up to three
passages. Thus, under appropriate conditions the fli:GFP+ and
kdrl:GFP+ cells can be maintained for longer duration in vitro.
Another reason for the disappearance of the fli:GFP+ or kdrl:GFP+
cells in cultures can be considered in the light of previous in vivo stu-
dies, showing that GFP expression in fli:GFP embryos persist at least up
to 7 days post fertilization (dpf) [37]. Similarly, studies on mouse
embryos and embryonic stem cells have shown a significant reduction
in the expression levels of flk1/kdr gene at advanced developmental
stages [55]. Based on those reports, the results of the current study
suggest that as the endothelial cells mature in our zebrafish blastocyst
cell cultures, they down-regulate the GFP expressing transgenes.
4.2. EB versus adherent culture
Research on mouse embryonic stem cell culture has shown that EBs
grown in attached cultures contained a higher number of total cells and
a lower percentage of hematopoietic and endothelial cells, compared to
embryoid bodies grown in suspension cultures [56]. Our results in
zebrafish embryonic cell cultures are consistent with these findings. In
the present study, zebrafish blastocyst cells cultured in basic LDF
medium developed a few, large-sized EBs, while cells cultured in LDF
medium supplemented with endothelial growth medium, or endothelial
growth supplements, developed more numerous, but smaller EBs with a
higher percentage of fli:GFP+ or kdrl:GFP+ cells. These results suggest a
direct relationship between the number of EBs and the percentage of
fli:GFP+ or kdrl:GFP+ cells.
In the adherent cultures, the cells grow in a monolayer around the
EBs. Cultures showing few, large-sized EBs contain a higher number of
adherent cells in the form of a monolayer. In this monolayer, there is
less cell-to-cell contact than there is in the EBs, and it is possible that
this relative lack of contact favors the growth or differentiation of cell
types other than hematopoietic and endothelial cells, as previously
suggested [56]. In contrast, cultures showing more numerous small-size
EBs contain a higher number of cells as part of the EBs, where there is
more cell-to-cell contact and is apparently favorable for the growth or
differentiation of fli:GFP+ and kdrl:GFP+ cells. This conclusion is
Fig. 9. Changes with time in the parameters of kdrl:GFP+ cell networks on
different substrates. (A) Total length of kdrl:GFP+ cell network per EB on
different 2D substrates and in 3D gel matrix. (B) Average branch length per EB
of kdrl:GFP+ cell network on different 2D substrates and in 3D gel matrix. The
graphs shows higher length of kdrl:GFP+ cell network in 3D culture compared
to 2D culture. Number of observations: 14 for 2D collagen type-I, 12 for 2D
Geltrex™, 11 for 2D collagen type-I + Geltrex™ and 11 for 3D collagen type-
I + Geltrex™ + Fibrin. Error bars represent standard error. (***, p < 0.001,
**, p < 0.01, *, p < 0.05 compared to 2D collagen (I); ###, p < 0.001, ##,
p < 0.01, #, p < 0.05 compared to 2D Geltrex™; +++, p < 0.001, ++,
p < 0.01, +, p < 0.05 compared to 2D collagen (I) + Geltrex™).
Fig. 10. Connectedness of kdrl:GFP+ cell network on different substrates.
Values nearest to zero on the vertical axis show a well-connected network. On
collagen type-I substratum the network connectedness deteriorate with time,
while on 2D collagen type-I + Geltrex™ substrate and in 3D collagen type-
I + Geltrex™ + fibrin matrix comparatively well-connected network is main-
tained until the end of culture. Error bars represent standard error. (***,
p < 0.001, **, p < 0.01, *, p < 0.05 compared to collagen type-I sub-
stratum).
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supported by our hanging-drop experiments in which there is by defi-
nition no outgrowth, but there is a high percentage of fli:GFP+ or
kdrl:GFP+ cells. EB intermediate formation has been used as a method
of choice to induce specific differentiation in mouse and human ESCs
[57].
The transcriptome analysis of endothelial markers of EB and ad-
herent blastocyst cell culture, in our experiments, also showed an in-
creased expression of TGF-β and VEGF in EB cultures. These results
suggest that TGF-β and VEGF are candidate genes involved in the dif-
ferentiation of endothelial-like cells (fli:GFP+ or kdrl:GFP+ cells), and
that their expression is favored by the suspension EB culture. In pre-
vious studies, VEGF has been recognized as the main endothelial cell
survival and differentiation factor [58]. Similarly, TGF-β has been
reported to be involved in the vascular development of early embryos
[59]. The transcriptome analysis, in the current study, also showed an
increase expression of Notch receptors in the EB cultures. Previous
studies have shown that Notch signaling is induced in response to
VEGF, promoting the specification of arterial endothelial cells [60].
These results are in accordance with our 3D EB cultures which showed
the kdrl:GFP+ cells forming vascular network-like structures, unlike the
2D adherent cultures in which the kdrl:GFP+ cells showed a less vessels-
like morphology, rather growing in a monolayer.
The EB cultures showed a comparatively higher expression of the
pluripotency marker (Pou5f) than the blastocyst cell culture on day 2.
These results suggest the maintenance of pluripotency for a longer
duration in the suspension EB culture compared to the adherent
Fig. 11. Heatmap showing the expression values (FPKM) of different genes at subsequent days of blastocyst cells and EB culture. Both culture types were
maintained on the same media (LDF:EGS + 40 ng/ml VEGF165). The values at day 0 is the expression level of genes in the blastocyst embryos used to initiate both
culture types. The number of observations was two for each time-point and culture type.
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cultures. This may explain why EB formation has been shown to pro-
vide better control over cellular differentiation [57]. Furthermore, re-
duced proliferation (as was observed in the transcriptome analysis of
our EB cultures) has also been reported as a requirement to control the
differentiation of ES cells towards specific lineage [57].
Our results show that the zebrafish EB model can be an important
tool to study the differentiation of endothelial cells and the formation of
vascular networks in vitro. It would also be possible to isolate live en-
dothelial (kdrl:GFP+) cells from these cultures using fluorescence-acti-
vated cell sorting (FACS). The development of vascular networks in vitro
from these cells under specific conditions can be tracked in real-time
using the GFP marker.
4.3. Effects of medium composition
LDF is a commonly-used medium for zebrafish embryonic cell cul-
ture [42–45,61]. Zebrafish primary blastocyst cells have more complex
nutrient requirements for their growth and attachment [62,63] there-
fore supplements including FBS, fish embryo extract, fish serum and
bFGF are usually added to the medium. A nutrient-rich medium is re-
quired, possibly because the initial cell death is high in these cells as a
result of embryo sterilization procedure [63]. The blastocyst cells are
pluripotent in nature; therefore, specific differentiation pathways can
be promoted by selective culture conditions [35]. In some experiments,
additional supplementation or a substrate coating may be required to
induce specific differentiation in these cells. Examples include sonic
hedgehog protein for myocyte differentiation [64], and poly-D-lysine
coating for neuron and astrocyte differentiation [44].
Endothelial growth medium (EGM) is usually used to culture human
umbilical vein endothelial cells (HUVECs [46,47]), as well as for the
differentiation of human pluripotent stem cells into vascular en-
dothelial cells [13]. The complete EGM is a combination of endothelial
basal medium and endothelial growth supplement (EGS) mix. The EGS
is composed of growth factors including human epidermal growth
factor, bFGF, insulin-like growth factor (IGF-1) and human VEGF. These
components are usually used in differentiation media to induce en-
dothelial differentiation in mouse [12,29] and human [12,31,32] em-
bryonic stem cells. Other components of EGS are heparin and hydro-
cortisone, which have also been used for endothelial differentiation in
human ES cells [32]. Similarly, ascorbic acid found in EGS has also been
used in endothelial differentiation medium for mouse ES cell culture
[12].
LDF medium supplemented with endothelial growth supplement
(EGS) significantly increased the percentage of fli:GFP+ and kdrl:GFP+
cells in our experiments. LDF is defined as a standard medium in many
zebrafish cell culture procedures [42–45,61]. The EGS contains the
necessary factors required for the growth of endothelial and hemato-
poietic cells as discussed above. Therefore, the combination of LDF
medium and EGS represents a medium that can induce maximum dif-
ferentiation of fli:GFP+ and kdrl:GFP+ cells in cultures. The LDF:EGM
medium also showed a higher percentage of fli:GFP+ cells in our ex-
periments; however, the total number of cells harvested per well from
the LDF:EGM medium was lower than the other media that contained
LDF as a major component.
To obtain pluripotent embryonic stem cells, zebrafish blastocyst
cells have been cultured on a feeder layer of growth-arrested stromal
cells in the LDF medium [42,43,65]. Without the support of a feeder
layer, the blastocyst cells differentiate into embryoid bodies – that
contain various cell types and adherent fibroblast-like cells [62]. In
further passages, only the adherent cell type that is best adapted to the
medium remains in the culture [61,66]. These studies suggest the
suitability of the LDF medium for growth and differentiation of cells
other than fli:GFP+ and kdrl:GFP+ cells. However, we found, in this
study, that the addition of EGS and VEGF165 to the LDF medium in-
creased the percentages of fli:GFP+ and kdrl:GFP+ cells compared to
cultures in basic LDF medium.
4.4. Effect of substrate composition
Extracellular matrix (ECM) is an important component of tissues in
vivo, and it directly interacts with cells by receptors and supports their
growth and differentiation [67]. Different tissues possess ECM of dif-
fering composition and physical properties (stiffness, elasticity, etc.),
that influence the behavior and differentiation of cells in that tissue
[67]. The same principle applies to the cells in vitro. Different ECM
substrates have been identified as directing the differentiation of ES
cells towards different cell lineages, as is reviewed in Refs. [68]. Some
ECM substrates including collagen type I [29,30], collagen-IV [21], and
gelatin [12,33], have been used to stimulate endothelial differentiation
in mouse embryonic stem cells. Fibronectin has also been used to
promote the differentiation of human ES cells along endothelial lineage
[32]. In our previous studies, fibronectin substratum was found to in-
crease the attachment of kdrl:GFP+ cells recovered from the hearts of 5
dpf zebrafish larvae [39].
In the current study, the blastocyst cells cultured on collagen type-I
substratum contained higher percentages of fli:GFP+ and kdrl:GFP+
cells, compared to gelatin substratum. However, no significant differ-
ences in the percentages of fli:GFP+ and kdrl:GFP+ cells were observed
between collagen type-I and plastic substrates. This may suggest the
suitability of collagen type-I over gelatin for zebrafish cell culture in
general. However, it also shows that collagen type-I is not necessary for
the differentiation of endothelial cells at the early stages. Research on
zebrafish ECM has shown the production of fibronectin and laminin in
early developing embryos, and the synthesis of collagen at later stages
[69]. Similarly, another study described the role of collagen type I in
the development of blood vessels at the latter stages in vascular tube
formation [70].
The in vivo shift from fibronectin and laminin in early embryos to-
wards collagen type I in later embryos might explain some of our
findings in vitro (specifically the comparison between blastocyst cul-
tures and EB cultures). In the EB cultures, cells are at an advanced stage
of differentiation compared to the blastocyst cell cultures. The fli:GFP
EB cultures on collagen type-I substratum showed a slow increase in
area covered by fli:GFP+ cells compared to gelatin and fibrin substrates
up to day 6 of culture. And then from day 6 to day 8 a fast increase was
recorded on collagen type-I compared to other substrates. The length
and connectedness of kdrl:GFP+ cell network per EB on the substrates
containing both collagen type-I and fibrin was higher compared to pure
collagen type-I or Geltrex™ substrates. These results are in accordance
with previous studies where the combination of collagen type-I and
fibrin has been found to be favorable for vascular network formation
from human endothelial progenitor cells [46]. These results may also
suggest the requirement of multiple extracellular components for the
formation of vascular networks in zebrafish blastocyst cell culture.
4.5. VEGF affects the growth of fli:GFP+ and kdrl:GFP+ cells
VEGF is known to be an important factor for the differentiation and
growth of endothelial cells in early embryogenesis, as well as for the
development of vascular networks in embryos and adult tissues [71].
VEGF has been shown to increase endothelial differentiation in human
embryonic stem cell culture [72]. In our experiments, the percentage of
fli:GFP+ cells was 5.0 fold higher, and kdrl:GFP+ cells 2.9 fold higher,
in cultures supplemented with 40 ng/ml VEGF165 compared to cultures
without VEGF165. These results are comparable with a previous study
on human embryonic stem cells where VEGF at 50 ng/ml has been
reported to increase endothelial differentiation by 4.7 fold [72].
5. Conclusions
The growth of endothelial-like (fli:GFP+ and kdrl:GFP+) cells can be
enhanced in zebrafish blastocyst cell cultures by adding endothelial
growth supplements and factors to the medium. We describe an
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optimized procedure for enhancing differentiation of endothelial-like
cells in zebrafish blastocyst cells. The suspension EB culture favored
more the differentiation of fli:GFP+ and kdrl:GFP+ cells and showed a
higher expression of endothelial markers, compared to the adherent
culture. A combination of different substrate components is required for
the formation of vascular-like (kdrl:GFP+) networks from zebrafish
blastocyst cells in vitro. A 3D culture supports the formation of
kdrl:GFP+ cell networks compared to 2D culture.
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